Stem Cell Therapies

FDA MSC Consortium Stem Cell Research

The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying adult mesenchymal stem cells (MSCs), which could eventually be used to repair, replace, restore or regenerate cells in the body, including those...

cardiac stem cell therapy
For years researchers have experimented with stem cells in attempts to regrow myocardium in patients who suffer permanent tissue damage from myocardial infarction. A handful of companies are pushing forward with clinical trials of their technologies...
CorMatrix Cardiovascular ECM Enrollment RESTORE Study Poland
CorMatrix Cardiovascular Inc. of Roswell, Ga., and the Central Clinical Hospital of the Ministry of Interior in Warsaw (Centralny Szpital Kliniczny MSW) of...
Capricor Therapeutics Inc. announced the execution of an Exclusive License Agreement with Cedars-Sinai Medical Center for intellectual property (IP) related to...
Researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI) revealed how a protein encourages the production of stem...
FDA MSC Consortium Stem Cell Research
The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying adult mesenchymal stem cells (MSCs), which could...
Ademedus CardioCel Stem Cell Therapy
Admedus’s CardioCel is a tissue product to repair and treat a range of cardiovascular and vascular defects.  The intended use of
Leonhardt Ventures and Core Manufacturing LLC announced its partnership in June 2013 to manufacture and bring to market a lineup of medical...

Articles

Researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI) revealed how a protein encourages the production of stem...
FDA MSC Consortium Stem Cell Research
The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying adult mesenchymal stem cells (MSCs), which could...
Cytori Stem Cell Therapy Heart Failure Treatments PRECISE Trial
Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical trial of Cytori Cell Therapy in patients with chronic...
Icahn Mount Sinai HDL LDL Nanotherapy Stem Cell Therapies Cath Lab
An international research team, led by Icahn School of Medicine at Mount Sinai investigators, designed and tested a high-density lipoprotein (HDL) nanoparticle...

Video Center

A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
1 week 5 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
2 weeks 4 days ago
The key cardiology news coming out of the 2014 meeting for the Society of Nuclear Medicine and...
4 weeks 4 days ago
CVIS, cardiovascular information system, webinar
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle efficiency benefits of a modern cardiovascular...
The webinar "Implementing Robotic PCI — Why and How to Start a Successful Program" defines optimal strategies for launching a successful robotic percutaneous coronary intervention (PCI) program. The...
This webinar focuses on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It offers an...

Comparison Charts

Sorry there is no data available